The Board of Directors of Aurobindo Pharma Limited has authorized a buyback plan on July 18, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,336 INR | -2.53% |
|
+1.40% | +23.28% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.28% | 9.61B | |
+55.35% | 815B | |
+32.04% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+12.80% | 250B | |
+16.30% | 247B | |
+16.54% | 180B | |
+4.31% | 170B |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- Aurobindo Pharma Limited authorizes a Buyback Plan.